Primary screening for HPV provides 60% to 70% greater protection against invasive cervical cancer than the cytology-based (smear test) screening currently used.
For people with a family history of adenomas, up to 10% of colorectal cancers could be missed when current national screening guidelines are followed.
A survey finds that most patients are not being told about the possibility of overdiagnosis and overtreatment as a result of cancer screenings.
Many people caring for a family member with dementia want to put an end to screening the person for cancer as the dementia progresses, and are relieved when health care providers bring up the topic, according to the findings of a small focus-group study.
A new streamlined method rapidly identifies genetic changes in small protein fragments unique to melanoma cancer cells.
Centers in the United States can achieve a 20% reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening that was previously reported by the National Lung Screening Trial (NLST).
A new genomic approach for screening compounds has identified a compound that causes neuroblastoma cells to differentiate. This new strategy screens for compounds that could inhibit tumor growth by causing cancer cells to differentiate.
Exposure to Agent Orange has been linked to lethal forms of prostate cancer among US veterans by a new analysis.
Pioneering biophotonics technology is the first screening method to detect the early presence of ovarian cancer in humans
High-quality CT colonoscopy diagnostic images can be maintained while reducing the radiation dose, according to a new study.
The digital rectal examination is an important screening test that can discover prostate cancer that a PSA test may not, despite the higher sensitivity of the PSA test.
A new immunoassay that tests for the presence of three biomarkers appears to be a valid screening method for the early detection of malignant kidney cancer. The immunoassay measured the levels of three potential biomarkers for kidney cancer.
A new study adds support to current medical recommendations stating that screening colonoscopy substantially reduced the likelihood of advanced CRC in either the right or left side of the colon being diagnosed in an average-risk adult.
Researchers used electronic EHRs to identify patients in a health care cooperative who were not screened regularly for cancer of the colon and rectum, and to encourage them to be screened.
A pilot study of the PapGene test, which relies on genomic sequencing of cancer-specific mutations, accurately detected all 24 (100%) endometrial cancers and nine of 22 (41%) ovarian cancers.
Cancer survivors meet U.S. Healthy People 2010 goals for all screening except cervical cancer.
Providing information tools to help people decide whether to undergo colorectal cancer screening leads to them being more likely to request the procedure.
The American Society of Clinical Oncology has released a nearly 100-page report detailing the year's most significant developments in cancer.
The radiation dose to areas of the body near the breast during mammography is negligible, or very low, and does not result in an increased risk of cancer, according to a new study.
Adding three-dimensional breast imaging to standard digital mammography increases diagnostic accuracy and reduces false-positive recall rates.
A new modeling study has found that people who undergo colonoscopy at age 50 years in which no precancerous polyps are found can be rescreened at age 60 years with one of three alternative methods, rather than undergoing colonoscopy every 10 years.
Adding three-dimensional imaging to standard digital mammography significantly increases the diagnostic accuracy of radiologists while reducing the rate of false positive recalls.
Black women have the highest death rate from breast cancer of all racial and ethnic groups, and are 40% more likely to die of the disease than are white women, according to a new report from the CDC.
It may be reasonable to use methods other than colonoscopy to rescreen people who had negative results on their first screening colonoscopy.
The new method produces 3D diagnostic computed tomography images with a spatial resolution that is two or three times higher than present hospital scanners, but has a radiation dose that is 25x lower.
Assessing how water moves through breast tissue may reduce false-positive findings among women undergoing dynamic contrast-enhanced MRI.
A simple three-question survey has been developed to help clinicians identify women who may be experiencing symptoms of ovarian cancer.
The use of colonoscopy to screen for colorectal cancer may explain the significant decrease in the incidence of that cancer over the past decade. While colonoscopy is now the most common colorectal cancer screening method, evidence has conflicted about how its effectiveness compares with sigmoidoscopy.
Two of three main recommendations for colonoscopy surveillance are now supported by stronger evidence than they were in 2006.
Among patients with colorectal cancer, 29% in a nationally representative sample were diagnosed after an emergency, such as an obstruction or perforation of the bowel.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|